Table S1.
Baseline demographic, clinical, and laboratory characteristics of all non-CAKUT patients included in the database used for propensity score matching.
| Characteristics | Non-CAKUT (n = 320) |
|---|---|
| Donor age (years), median (IQR) | 46.0 (35.0–54.0) |
| Donor sex, % | |
| Male | 50.9 |
| Female | 49.1 |
| Recipient sex, % | |
| Male | 61.2 |
| Female | 38.8 |
| Recipient age (years), median (IQR) | 32.0 (25.0–41.0) |
| Donor type, % | |
| Living | 74.7 |
| Deceased | 25.3 |
| Follow-up duration (months), median (IQR) | 146.0 (100.0–185.5) |
| HLA mismatches, % | |
| ≤3 | 18.1 |
| >3 | 81.9 |
| Duration of dialysis (months), median (IQR) | 18.0 (6.0–36.5) |
| Pretransplant KRT, % | |
| No (Preemptive) | 12.5 |
| Yes (HD and/or PD) | 87.5 |
| Immunosuppressive regimen, % | |
| Tac/MPA/steroids | 51.3 |
| CsA/MPA/steroids | 21.9 |
| Tac/AZA/steroids | 9.1 |
| CsA/AZA/steroids | 3.0 |
| Others | 14.7 |
Abbreviations: AZA: azathioprine; CAKUT: congenital anomalies of the kidney and urinary tract; CsA: cyclosporine; HD: hemodialysis; IQR: interquartile range: human leukocyte antigen; KRT: kidney replacement therapy; MPA: mycophenolic acid; PD: peritoneal dialysis; Tac: tacrolimus.